In This Section

Xiao-Feng Yang, MD, PhD, FAHA

Professor and Associate Director, Lemole Center for Integrated Lymphatics and Vascular Research
Professor, Cardiovascular Sciences
Professor, Center for Metabolic Disease Research
Professor, Microbiology, Immunology & Inflammation
Professor, Sol Sherry Thrombosis Research Center
Professor, Biomedical Education & Data Science

Xiao-Feng Yang
Contact Information

Contact Information



About Me

Research Interests

  1. Vascular immunology and atherosclerosis. Dr. Yang’s laboratory uses microarray transcriptome, next generation DNA sequencing including RNA-Seq, T cell epitope mapping, SEREX and other biochemical, immunological approaches and transgene/gene knock-out disease models in order to determine cardiovascular disease (CVD) risk factors, such as hyperlipidemia-, hyperglycemia-, uremia-, endotoxemia, impact the development/progression of vascular inflammation and atherosclerosis.
  2. Immunometabolism. Dr. Yang’s laboratory also aims to study how biochemical metabolites in CVD-related pathologies act as either danger signals or homeostatic signals to regulate antigen processing/presentation, vascular immune responses and atherosclerosis.
  3. Epigenetic pathology. Dr. Yang’s laboratory also studies how CVD risk factors regulate histone modification process and gene expressions in vascular inflammation and atherosclerosis.
Education, Training & Credentials

Educational Background

  • Fellowship, Immunology and Oncology, Harvard Medical School, 1999
  • PhD, Biochemistry and Molecular Biology, University of Montreal, Canada 1994
  • MS, Immunology, Chinese National Academy of Medical Sciences and Peking Union Medical University 1982   
  • MD, Clinical Medicine, JiangXi Medical University, China 1979

Digital Bibliography

View PubMed Publications